Munafa Stock Market Course + Intraday & FNO calls 
Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Supernus Pharmaceuticals (SUPN)
Technical Analysis Report for NASDAQ stock SUPN Supernus Pharmaceuticals. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock SUPN Supernus Pharmaceuticals then click here. or read Experts views on Supernus Pharmaceuticals or Forecast & share price targets of Supernus Pharmaceuticals
Supernus Pharmaceuticals Opened at 50.01 and Closed at: 51.65, which is 4.41% of previous session's close. It moved within a range of 50.01 and 51.99
The session was a Bullish session with an average volume of 893900, which is 36.74% of previous session's volumes.
- There is some positive change in the short term trend, but its too soon to jump onto conclusions.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
Support for tomorrow is 50.83 and resistance for tomorrow is 52.81
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 50.44, 49.24 resistance for tomorrow's hourly charts is 52.42, 53.2
10 Day SMA for Supernus Pharmaceuticals (SUPN) is 49.2 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Supernus Pharmaceuticals (SUPN) is 49.74 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Supernus Pharmaceuticals (SUPN) is 48.85 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 48.68 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Supernus Pharmaceuticals is 42.27 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Supernus Pharmaceuticals is at 49.74 and 200 DMA is at 42.27, while 50 DMA and 100 DMA are at 48.85 and 48.68 respectively
Supernus Pharmaceuticals (SUPN) moving average of 20 SMA is at 49.74 and 20 EMA is at 49.51
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 51.65 | 49.74 | 49.51 |
| 05 Thu Feb | 49.37 | 49.71 | 49.29 |
| 04 Wed Feb | 49.08 | 49.81 | 49.28 |
| 03 Tue Feb | 48.40 | 49.81 | 49.3 |
| 02 Mon Feb | 48.78 | 49.86 | 49.4 |
| 30 Fri Jan | 48.16 | 49.9 | 49.46 |
Supernus Pharmaceuticals (SUPN) moving average of 50 SMA is at 48.85 and 50 EMA is at 49.08
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 51.65 | 48.85 | 49.08 |
| 05 Thu Feb | 49.37 | 48.72 | 48.98 |
| 04 Wed Feb | 49.08 | 48.64 | 48.96 |
| 03 Tue Feb | 48.40 | 48.55 | 48.96 |
| 02 Mon Feb | 48.78 | 48.5 | 48.98 |
| 30 Fri Jan | 48.16 | 48.42 | 48.99 |
Supernus Pharmaceuticals (SUPN) moving average of 100 SMA is at 48.68 and 100 EMA is at 47.47
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 51.65 | 48.68 | 47.47 |
| 05 Thu Feb | 49.37 | 48.6 | 47.39 |
| 04 Wed Feb | 49.08 | 48.56 | 47.35 |
| 03 Tue Feb | 48.40 | 48.54 | 47.32 |
| 02 Mon Feb | 48.78 | 48.52 | 47.3 |
| 30 Fri Jan | 48.16 | 48.49 | 47.27 |
Supernus Pharmaceuticals (SUPN) moving average of 200 SMA is at 42.27 and 200 EMA is at 44.13
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 51.65 | 42.27 | 44.13 |
| 05 Thu Feb | 49.37 | 42.17 | 44.05 |
| 04 Wed Feb | 49.08 | 42.07 | 44 |
| 03 Tue Feb | 48.40 | 41.98 | 43.95 |
| 02 Mon Feb | 48.78 | 41.89 | 43.91 |
| 30 Fri Jan | 48.16 | 41.8 | 43.86 |
Utah Medical has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Utah Medical, about 1.84% more returns!
Supernus Pharmaceuticals has performed better than United Therapeutics in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Natera Inc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Medpace Holdings in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Madrigal Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Ligand Pharmaceuticals in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Anaptysbio Inc has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Anaptysbio Inc, about 10.27% more returns!
Atossa Genetics has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Atossa Genetics, about 720.48% more returns!
Supernus Pharmaceuticals has performed better than Anavex Life in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Caredx Inc has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Caredx Inc, about 12.6% more returns!
Ensign Group has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Ensign Group, about 12.7% more returns!
Supernus Pharmaceuticals has performed better than Exelixis Inc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Halozyme Therapeutics has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Halozyme Therapeutics, about 11.03% more returns!
Supernus Pharmaceuticals has performed better than Hologic Inc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Supernus Pharmaceuticals has performed better than Icon Plc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Incyte Corporation has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Incyte Corporation, about 0.36% more returns!
Supernus Pharmaceuticals has performed better than Insmed Inc in short term. Holding Supernus Pharmaceuticals could be a better choice for now!
Innoviva Inc has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Innoviva Inc, about 10.28% more returns!
Ionis Pharmaceuticals has performed better than Supernus Pharmaceuticals in short term. You could have earned much better returns by investing in Ionis Pharmaceuticals, about 6.66% more returns!
Supernus Pharmaceuticals Technical analysis of indicators
Price action analysis of Supernus Pharmaceuticals (SUPN) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Supernus Pharmaceuticals stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Supernus Pharmaceuticals in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Supernus Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Supernus Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Supernus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 49.21 and Supernus Pharmaceuticals SUPN stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Supernus Pharmaceuticals SUPN stock. Volume based technical analysis of Supernus Pharmaceuticals SUPN stock is negative.
Supernus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock SUPN Supernus Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And SUPN Experts View which covers a lot of information including buying and selling signals
SUPN future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Supernus Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Supernus Pharmaceuticals (SUPN) Technical (Analysis) Reports Supernus Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
